维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

11篇 您的检索式：作者名="Arbea"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Current treatment of rectal cancer adapted to the individual patient显示文摘	Laura Cerezo Juan Pablo Ciria Leire Arbea Olga Li?án Sergio Cafiero Vincenzo Valentini Francesco Cellini	2013	Reports of Practical Oncology & Radiotherapy2013，，6：	1
	2	Phase I - II trial of concurrent capecitabine and oxaliplatin with preoperative intensitymodulated radiotherapy in patients with locally advanced rectal cancer 显示文摘	Aristu JJ Arbea L Rodriguez J	2008	Int J Radiat Oncol Biol Phys2008，71，：	1
	3	Primary bone lymphoma of the mandible and thyroid incidentaloma identified by FDG PET/CT:a case report显示文摘	Bosch-Barrera J Arbea L García-Velloso MJ	2009	Cases J2009，2，：	1
	4	Four- week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: a validation phase 1I trial 显示文摘	Arbea L Martinez-Monge R Diaz-Gonz61ez JA	2012	Int J Radiat Oncol Biol Phys2012，83，：	1
	5	Current treatment of rectal cancer adapted to the individual patient 显示文摘	Cerezo L Ciria JP Arbea L	2013	Rep Pract Oncol Radiother2013，18，6：	1
	6	Intensity-modulated radiation therapy(IMRT) vs 3D eonformal radiotherapy(3DCRT) in locally advanced rectal cancer(LARC): Dosimetric comparison and clinical implications显示文摘	Arbea L Ramos LI Martinez-Monge R	2010	Radiat Oncol2010，5，：	1
	7	Primary bone lymphoma of the mandible and thyroid incidentaloma identified by FDG PET/CT:a case report显示文摘	Bosch-Barrera J Arbea L García-Velloso MJ	2009	Cases J2009，26，2：	1
	8	Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: a validation phase II trial 显示文摘	Arbea L Martfnez-Monge R Daz-Gonz61ez JA	2012	Int J Radiat Oncol Biol Phys2012，83，2：	1
	9	Current treatment of rec- tal cancer adapted to the individual patient 显示文摘	Cerezo L Ciria JP Arbea L	2013	Reports of Practical Oncology & Radiotherapy2013，18，6：	1
	10	Rectal cancer treatment: improving the picture显示文摘Multidisciplinary approach for rectal cancer treatment is currently well defined. Nevertheless, new and promising advances are enriching the portrait. Since the US NIH Consensus in the early 90's some new characters have been added. A bird's-eye view along the last decade shows the main milestones in the development of rectal cancer treatment protocols. New drugs, in combination with radiotherapy are being tested to increase response and tumor control outcomes. However, therapeutic intensity is often associated with toxicity. Thus, innovative strategies are needed to create a better-balanced therapeutic ratio. Molecular targeted therapies and improved technology for delivering radiotherapy respond to the need for accuracy and precision in rectal cancer treatment.	Juan A Diaz-Gonzalez Leire Arbea Javier Aristu	2007	World Journal of Gastroenterology2007，13，44：	0
	11	A case of capecitabine-induced coronary microspasm in a patient with rectal cancer显示文摘5 氟尿嘧啶(5-FU ) 是有在有直肠的癌症的病人的管理的放射疗法的最经常使用的化疗代理人伴随物。Capecitabine 是模仿 infusional 5-FU 的 pharmaconkinetics 的口头的 fluoropyrimidine。这新药作为很多胃肠的癌症的联合形式的治疗的部分正在代替 5-FU。当与 5-FU 的使用联系的心脏的事件是一个众所周知的副作用时,导致 capecitabine 的 cardiotoxicity 仅仅很少被报导了。这里,我们与直肠的癌症考察了一个病人的案例有导致 capecitabine 的冠的血管痉挛。dihydropyrimidine 脱氢酶基因的最突出的变化也被分析。	Leire Arbea Isabel Coma-Canella Rafael Martinez-Monge Jesús García-Foncillas Radiation Oncology Division	2007	World Journal of Gastroenterology2007，13，14：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费